Latest News
Washington, D.C. — U.S. Representative Mike Rogers (R-AL), Chairman of the House Armed Services Committee, released a statement after the Department of Defense rescinded the COVID-19 vaccine mandate for servicemembers.
Washington, D.C. – United States Representative Mike Rogers (R-AL) released the following statement after being named Chairman of the House Armed Services Committee. Rep. Rogers will be the first Congressman from Alabama to serve as Chairman of the committee.
Washington, D.C. – U.S. Representative Mike Rogers (R-AL), Lead Republican of the House Armed Services Committee, sent a letter to Secretary of Defense Lloyd Austin, asking that the Department of Defense (DoD) provide Congress with a plan for rescinding the COVID-19 vaccine mandate for U.S. servicemembers. The James M. Inhofe National Defense Authorization Act for Fiscal Year 2023, which was signed into law last week, required DoD to rescind the COVID-19 vaccine mandate for U.S.
Washington, D.C.
Washington, D.C. – U.S. Representatives Mike Rogers (R-AL) and Adam Smith (D-WA), Ranking Member and Chairman of the House Armed Services Committee, released a statement detailing their support for Japan’s strengthened defense agenda.
Washington, D.C. – U.S. Representative Mike Rogers (R-AL), Lead Republican of the House Armed Services Committee, delivered the following opening statement at the full committee markup for H. Res. 1475.
Lead Republican Rogers’ remarks as prepared for delivery:
Thank you Mr. Chairman.
I support this Resolution of Inquiry.
Washington, D.C. – U.S. Representative Mike Rogers (R-AL), Lead Republican of the House Armed Services Committee, released the following statement on the House passage of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023.
Washington, D.C. – U.S. Representative Mike Rogers (R-AL), Lead Republican of the House Armed Services Committee, delivered the following remarks on the House floor in support of the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023.